Abstract:Background: Neuropsychiatric lupus erythematosus (NPSLE) has a range of clinical manifestations, among which mood disorders are one of the common subtypes. These mood disorders, particularly depression, significantly impact the quality of life for SLE patients and may even lead to suicidal thoughts or behaviors. Currently, the pathogenesis of lupus-related depression is unknown, and clinical intervention measures are limited. Total glucosides of paeony (TGP), a Chinese patent medicine primarily composed of paeoniflorin, has been shown to possess anti-inflammatory and immunomodulatory effects as well as potential antidepressant properties. Regulating intestinal metabolic disorders by improving the structure of intestinal flora is a new target of antidepressants in recent years. Objectives: This study aims to investigate the regulatory effects of TGP on intestinal flora and metabolites in lupus mice, and to clarify the metabolic pathway of TGP in the treatment of lupus-related depression. Methods: 30 female MRL/lpr mice were randomly divided into 3 groups with 10 mice in each group. Additionally, 10 age-matched MRL/MPJ mice were subjected to adaptive feeding for one week followed by 4 consecutive weeks of treatment with TGP at different doses: LPR group (MRL/lpr mice + saline), LTGP group (MRL/lpr mice + 100mg/kg TGP), HTGP group (MRL/lpr mice + 200mg/kg TGP), and MPJ group (MRL/MPJ mice + saline). Then we conducted behavioral tests, renal function assessment, spleen and lymph node index determination, and measurements of relative levels of proinflammatory cytokines and brain-derived neurotrophic factor (BDNF) in peripheral blood. The fecal samples from each group were analyzed using 16S rRNA sequencing and metabolomics techniques to examine changes in gut flora composition and metabolite profiles. Furthermore, correlation analysis was performed among differential bacterial genera, metabolites and indicators. Results: Compared with the LPR group, the TGP groups showed significant relief in renal injury, spleen and lymph node enlargement, as well as improvement in depressive-like behavior. The TGP groups also showed relief in intestinal permeability and inflammation. Additionally, in TGP groups, the levels of proinflammatory cytokines in peripheral blood and brain regions were decreased, and the level of BDNF in the brain was increased. Compared with MPJ group, the abundance of Bacteroidetes was decreased, the abundance of Firmicutes was increased, and the ratio of Firmicutes to Bacteroidetes (F/B) was decreased in LPR group, while the composition of intestinal microorganisms in LTGP and HTGP groups was improved to varying degrees. Furthermore, we analyzed the differential metabolites and related metabolic pathways between LPR group and MPJ group, and between LPR group and HTGP group. The results showed that the differential pathways were primarily associated with depression. Specifically, the metabolites of the tryptophan pathway, including L-Tryptophan, Serotonin, L-Kynurenine, and Melatonin, showed significant differences between the LPR and MPJ groups. In LPR group and HTGP group, the metabolites of Serotonin, L-Kynurenine, and 6-Hydroxymelatonin showed significant differences. Correlation analysis showed that the abundance of Parabacteroides was positively correlated with inflammatory indicators, and negatively correlated with BDNF expression level. In the metabolites related to tryptophan pathway, the expression level of BDNF in the prefrontal cortex and hippocampus was negatively correlated with the contents of DL-Tryptophan, L-Tryptophan, Serotonin, and L-Kynurenine, and positively correlated with the contents of Melatonin and 6-Hydroxymelatonin. Conclusion: TGP can improve the lupus-like behavior of MRL/lpr mice. The relief of depression-like behavior in mice may be related to the regulation of intestinal microbiota and metabolites. REFERENCES: NIL. Acknowledgements: NIL. Disclosure of Interests: None declared.

Geniposide Protects Depression Through BTK/JAK2/STAT1 Signaling Pathway in Lipopolysaccharide-Induced Depressive Mice

Geniposide exerts the antidepressant effect by affecting inflammation and glucose metabolism in a mouse model of depression

Combination of Geniposide and Eleutheroside B Exerts Antidepressant-like Effect on Lipopolysaccharide-Induced Depression Mice Model

IL-6 expression-suppressing Lactobacillus reuteri strains alleviate gut microbiota-induced anxiety and depression in mice

Mechanistic Studies of Gypenosides in Microglial State Transition and its Implications in Depression-Like Behaviors: Role of TLR4/MyD88/NF-κB Signaling

Tert-Butylhydroquinone Prevents Neuroinflammation and Relieves Depression Via Regulation of NLRP3 Signaling in Mice

Ibrutinib Alleviates LPS-induced Neuroinflammation and Synaptic Defects in a Mouse Model of Depression

Isoginkgetin treatment attenuated lipopolysaccharide-induced monoamine neurotransmitter deficiency and depression-like behaviors through downregulating p38/NF-κB signaling pathway and suppressing microglia-induced apoptosis

Genipin 1-O-β-D-gentiobioside ameliorates CUMS-induced prefrontal cortex neuron neuronal apoptosis by modulating HIPK2 SUMOylation

AB1108 TOTAL GLUCOSIDES OF PAEONY ALLEVIATE DEPRESSIVE-LIKE BEHAVIORS IN LUPUS-PRONE MRL/lpr MICE BY MODULATING GUT MICROBIOTA AND METABOLITES

Ginsenoside Rk1 alleviates LPS-induced depression-like behavior in mice by promoting BDNF and suppressing the neuroinflammatory response

Neuroprotective effects of gypenosides on LPS-induced anxiety and depression-like behaviors

Geniposide ameliorates chronic unpredictable mild stress induced depression-like behavior through inhibition of ceramide-PP2A signaling via the PI3K/Akt/GSK3β axis

Ginsenosides modulate hypothalamic-pituitary-adrenal function by inhibiting FKBP51 on glucocorticoid receptor to ameliorate depression in mice exposed to chronic unpredictable mild stress

Genipin Attenuates Diabetic Cognitive Impairment by Reducing Lipid Accumulation and Promoting Mitochondrial Fusion via FABP4/Mfn1 Signaling in Microglia

Study on the antidepressant effect of panaxynol through the IκB-α/NF-κB signaling pathway to inhibit the excessive activation of BV-2 microglia

Geniposide Alleviates Oxidative Stress of Mice With Depression-Like Behaviors by Upregulating Six3os1

Betaine Inhibits NLRP3 Inflammasome Hyperactivation and Regulates Microglial M1/M2 Phenotypic Differentiation, Thereby Attenuating Lipopolysaccharide-Induced Depression-Like Behavior

Geniposide improves depression by promoting the expression of synapse-related proteins through the Creb1/Six3os1 axis

Geniposide improves depression-like behavior in prenatal stress male offspring through restoring HPA axis- and glucocorticoid receptor-associated dysfunction

Dlg1 Knockout Inhibits Microglial Activation and Alleviates Lipopolysaccharide-Induced Depression-Like Behavior in Mice